ArticleSurgical endoscopy2026
Omega gastric bypass versus long biliary limb Roux-en-Y gastric bypass: a retrospective analysis with 1- and 3-year follow-up.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne-anastomosis gastric bypass (OAGB) has gained popularity, although concerns persist regarding biliary reflux and malnutrition, particularly when the biliopancreatic limb exceeds 200 cm. The long biliary limb Roux-en-Y gastric bypass (LB-RYGB), featuring a 120 cm biliary limb, has been proposed to enhance total weight loss (TWL). This study compared TWL, remission of obesity-associated comorbidities, and outcomes at 1- and 3-year follow-up between OAGB (150 cm biliary limb) and LB-RYGB (120 cm biliary limb).
methodsPatients undergoing OAGB or LB-RYGB between February 2018 and February 2021 were evaluated at 1 and 3 years postoperatively. The primary endpoint was TWL at 1 year; secondary endpoints included TWL at 3 years, BMI, and postoperative outcomes.
resultsAmong 180 patients (127 OAGB, 53 LB-RYGB), median TWL did not differ at 1 year (26 [14-33] vs 25 [20-31]; p = 0.537) or 3 years (28 [18-32] vs 26 [19-32]; p = 0.856). Weight and BMI values were comparable at 1 and 3 years. Iron deficiency was more frequent after OAGB at 1 year (20% vs 6%; p = 0.032). Two OAGB patients required revision for anastomotic ulcers related to biliary reflux and one for stenosis with malnutrition, while internal hernias occurred exclusively after LB-RYGB (n = 3).
conclusionsOAGB and LB-RYGB appear equally effective for weight loss and resolution of obesity-associated comorbidities. Key complications differ, biliary reflux in OAGB and internal hernia in LB-RYGB. OAGB with a 150 cm biliary limb remains an effective option, and future randomized trials should further evaluate these specific complications.
Indexed as
Identifiers
42301461What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.